ArticleJournal of the American Heart Association2024

Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials.

Ankeet S Bhatt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.